NEW YORK STATE URBAN DEVELOPMENT CORPORATION d/b/a ...
NEW YORK STATE URBAN DEVELOPMENT CORPORATION d/b/a ...
NEW YORK STATE URBAN DEVELOPMENT CORPORATION d/b/a ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Market: Real Estate and Industrial/Economic Development<br />
ESD Involvement: After the acquisition of Wyeth by Pfizer in 2009, the decision was made<br />
to exit the Facility due to redundancy with other existing Pfizer research<br />
facilities and the retraction of Pfizer’s in-house research activities.<br />
From 2009 to 2010, the employee base was reduced until only a basic<br />
maintenance staff was left in place. During the two years since the<br />
closing, Pfizer has maintained the Facility and has also employed two<br />
different internationally known marketing firms to market the Facility.<br />
The current marketing firm is Cushman and Wakefield.<br />
Competition: N/A<br />
Past ESD Support: N/A<br />
B. The Project<br />
Completion: June 2014<br />
Over the last two years, there has been cursory interest in the Facility<br />
and site by potential purchasers. Barriers to purchase include significant<br />
operational costs and the large size of the Facility.<br />
The Facility was originally scheduled for auction on February 4, 2012<br />
(rescheduled for April 2, 2012), but at the request of ESD, Pfizer has<br />
delayed the auction. CCIDA, through CIDA, will acquire the Facility from<br />
Pfizer at a nominal cost so that the pending auction can be forestalled.<br />
This will provide more time and opportunity to present the Facility for<br />
acquisition by a responsible party, which would create investment and<br />
employment opportunities. ESD proposes to make a working capital<br />
grant of $1,200,000 to CIDA for operational costs while the Facility is<br />
being marketed to a new end user.<br />
Activity: CIDA will acquire, maintain and promote the Facility to potential new<br />
end users. The site has been used, continually upgraded and improved as<br />
a premier pharmaceutical research facility, has sophisticated private<br />
water and sewage treatment facilities, and is served by natural gas. CIDA<br />
intends to enter into a management agreement with a third party for the<br />
day-to-day operations of the Facility.<br />
Results: The project is expected to engage an end user that will create<br />
investment and employment opportunities in Chazy.<br />
3